Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 1;18(5):e202200617.
doi: 10.1002/cmdc.202200617. Epub 2023 Jan 16.

A Synthetic Overview of Benzoxazines and Benzoxazepines as Anticancer Agents

Affiliations
Review

A Synthetic Overview of Benzoxazines and Benzoxazepines as Anticancer Agents

Indranil Chatterjee et al. ChemMedChem. .

Abstract

Benzoxazines and benzoxazepines are nitrogen and oxygen-containing six and seven-membered benzo-fused heterocyclic scaffolds, respectively. Benzoxazepines and benzoxazines are well-known pharmacophores in pharmaceutical chemistry, which are of significant interest and have been extensively studied because of their promising activity against various diseases including their wide range of anticancer activity. Several reports are known for synthesizing benzoxazine and benzoxazepine-based compounds in the literature. Herein this review provides a critical analysis of synthetic strategies towards benzoxazines and benzoxazepines along with various ranges of anticancer activities based on these molecules that have been reported from 2010 onwards. This review also focuses on the structure-activity relationship of the benzoxazine and benzoxazepine scaffolds containing bioactive compounds and describes how the structural modification affects their anticancer activity.

Keywords: anticancer agents; benzoxazepines; benzoxazines; bioactive molecules; synthetic approaches.

PubMed Disclaimer

References

    1. None
    1. National Cancer Institute. 17 September 2007. Retrieved 28 March 2018;
    1. P. Tarantino, S. M. Tolaney, Cancer Res. 2022, 82, 3659-3661.
    1. Z. Eslami-S, L. E. C. Hernandez, F. Thomas, K. Pantel, C. A. Panabieres, Br. J. Cancer 2022, 127, 800-810.
    1. J. Ferlay, M. Ervik, F. Lam, M. Colombet, L. Mery, M. Pineros, Intern. Agency for Res. Cancer 2020, 43, 675-680.

Publication types

MeSH terms

LinkOut - more resources